US2023303482A1PendingUtilityA1

Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide

Assignee: DU PONTPriority: Sep 27, 2010Filed: Mar 24, 2023Published: Sep 28, 2023
Est. expirySep 27, 2030(~4.2 yrs left)· nominal 20-yr term from priority
Inventors:Joerg Bruening
C07C 231/02C07C 231/12C07C 231/14Y02P20/55C07C 237/06C07C 237/22
83
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods for preparing compounds of Formula 1 and 1A. The first method utilizes a benzyl carbamate amine protecting group and an intermediate of Formula 4. The second method utilizes a tert-butyl carbamate amine protecting group and an intermediate of Formula 7. The third method utilizes a dibenzyl amine protecting group. Also disclosed is a compound, phenylmethyl N-12-oxo-2-[(2,2.2-trifluoroeihyl)amino]ethyl]carbamate (a compound of Formula 4). Further disclosed is a method for preparing a compound of Formula 14 from a compound of Formula 15 and a compound of Formula 1 or 1A.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 - 15 . (canceled) 
     
     
         16 . A method for preparing a compound of Formula 14
                       comprising contacting in a polar aprotic water miscible solvent for 2 hours or more a compound of Formula 15                         with N, N′-carbonyldiimidazole to form an intermediate of Formula 16                         and carbon dioxide and imidazole, then directly treating the intermediate of Formula 16 with a compound of Formula 1 or 1A by adding a compound of Formula 1A                                               wherein X is Cl, Br, CF 3 CO 2 , CH 3 SO 3 , (SO 4 ) ½  or (PO 4 ) ⅓  and the compound of Formula 1A reacts with the intermediate of Formula 16 to produce the-compound of Formula 14, and wherein after completion of reaction of Formula 1A with the intermediate of formula 16 to produce the compound of Formula 14, adding an aqueous mineral acid to the compound of Formula 14 and then adjusting to pH 9-10 with a base.   
     
     
         17 . (canceled) 
     
     
         18 . The method of  claim 16  wherein the polar aprotic water miscible solvent comprises acetonitrile, tetrahydrofuran or dioxane. 
     
     
         19 - 20 . (canceled) 
     
     
         21 . The method of  claim 16  wherein the compound of Formula 1 or 1A is added as a solid or a solution in the polar aprotic water miscible solvent. 
     
     
         22 . The method of  claim 16  further comprising the step of adding water to hydrolyze any excess N, N′-carbonyldiimidazole prior to treating the intermediate of Formula 16 with the compound of Formula 1A, wherein the compound of Formula 1A is then added to the mixture as a solution or slurry in water. 
     
     
         23 . The method of  claim 22  wherein molar ratio of N, N′-carbonyldiimidazole to the compound of Formula 15 is from about 0.95 to about 1.15, molar ratio of the compound of Formula 1A to the compound of Formula 15 is from about 1.00 to about 1.15, the compound of Formula 15 and the N, N′-carbonyldiimidazole are contacted at a temperature of between 20° C. and 45° C. and the compound of Formula 1A is added at a temperature of between 20° C. and 45° C. 
     
     
         24 . The method of  claim 23  wherein the polar aprotic water miscible solvent comprises acetonitrile and X is Cl. 
     
     
         25 . The method of  claim 23  wherein the polar aprotic water miscible solvent comprises acetonitrile, tetrahydrofuran or dioxane. 
     
     
         26 . The method of  claim 22  wherein X is Cl. 
     
     
         27 . The method of  claim 22  wherein the compound of Formula 1A is contacted with the intermediate of Formula 16 in the presence of an additional base. 
     
     
         28 . The method of  claim 27  wherein the additional base is triethylamine or diisopropylethylamine. 
     
     
         29 . The method of  claim 22  wherein X is (SO 4 ) ½ . 
     
     
         30 . The method of  claim 21  wherein the polar aprotic water miscible solvent comprises acetonitrile, tetrahydrofuran or dioxane. 
     
     
         31 . The method of  claim 16  wherein the compound of Formula 1A is contacted with the intermediate of Formula 16 in the presence of an additional base. 
     
     
         32 . The method of  claim 31  wherein the additional base is triethylamine or diisopropylethylamine. 
     
     
         33 . The method of  claim 16  wherein:
 molar ratio of N, N′-carbonyldiimidazole to the compound of Formula 15 is from about 0.95 to about 1.15: 
 molar ratio of the compound of Formula 1A to the compound of Formula 15 is from about 1.00 to about 1.20; 
 the compound of Formula 15 and the N, N′-carbonyldiimidazole are contacted at a temperature of between 20° C. and 45° C.; and 
 the compound of Formula 1A is added at a temperature of between 20° C. and 45° C. 
 
     
     
         34 . The method of  claim 33  wherein:
 the molar ratio of N, N′-carbonyldiimidazole to the compound of Formula 15 is about 0.97: 
 the molar ratio of the compound of Formula 1A to the compound of Formula 15 is about 1.05; 
 the compound of Formula 15 and the N, N′-carbonyldiimidazole are contacted at a temperature of about 35° C.; and 
 the compound of Formula 1A is added at a temperature of about 35° C. 
 
     
     
         35 . The method of  claim 16  wherein X is Cl. 
     
     
         36 . The method of  claim 16  wherein mineral acid is hydrochloric acid and the base is sodium hydroxide or sodium carbonate. 
     
     
         37 . The method of  claim 16  wherein formation of the intermediate of Formula 16 is monitored by evolution of carbon dioxide gas.

Join the waitlist — get patent alerts

Track US2023303482A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.